Prostate Cancer Archive

After prostate cancer surgery, the patient’s prostate-specific antigen (PSA) is monitored by his doctor via a simple blood test. New research indicates that if the PSA increases following surgery, immediate radiation therapy can reduce the risk of cancer recurrence.

Following surgery to remove a cancerous prostate gland, some men experience a biochemical recurrence, meaning that prostate-specific antigen (PSA) has become detectable in their blood. Since only the prostate releases PSA, removing the gland should drop this protein to undetectable levels in the body. Detecting PSA could signify that prostate cancer cells are lingering, and […]

Two new studies add to the evidence that for many men with prostate cancer, if it is detected early and has not metastasized beyond the prostate gland, monitoring the cancer will lead to the same chance of survival after 10 as choosing surgery or radiation. Men treated with surgery or radiation often experience significant side effects. The rates of depression and anxiety were the same in men who opted for monitoring and those who opted for treatment.

Charles Schmidt A pair of new studies provides useful information to men facing challenging decisions about what to do after being diagnosed with early prostate cancer. Researchers tracked men for 10 years and found that virtually none died of the illness, even if they decided against treating it. Early prostate tumors confined to the prostate […]

A mindfulness-based stress reduction program (MBSR) can help control anxiety among men who follow active surveillance for prostate cancer. The wait-and-see approach can make men feel so uneasy about their condition that they opt for treatment with radiation therapy or surgery when it is unnecessary. MBSR not only eases anxiety levels, but also inspires men to be more proactive about their health and adopt lifestyle changes like a proper diet and exercise.

Once you've completed treatment, adjusting to a "new normal" can be challenging.

Image: RuslaGuzov/ Thinkstock

Completing cancer therapy can feel like a graduation. You've done some hard work, it's paid off, and you may be ready to celebrate. But saying goodbye to treatment can arouse many of the emotions and uncertainties associated with beginning a new chapter in life.

Dr. Larissa Nekhlyudov is a general internist who works with cancer survivors at two Harvard affiliates, Brigham and Women's Hospital and Dana-Farber Cancer Institute. She acknowledges that cancer survivors have a lot to deal with. "Once you've had your final chemotherapy infusion or swallowed the last pill, you may find yourself facing a new set of challenges—monitoring yourself for signs of recurrence, getting recommended follow-up care, adjusting to the long-term effects of treatment, psychologically adapting to normal life, and working to stay in good health," Dr. Nekhlyudov says.

Researchers believe that a non-invasive screening test that can identify genetic markers for high-grade prostate cancer in urine may eventually reduce the number of prostate biopsies needed. However, experts also caution that while the number of non-invasive tests for prostate cancer diagnosis is growing, these are still early days in their development.

Used alone or with hormone therapy, radiation can be a viable option for men at any stage of prostate cancer.

 Image: BigStock

Nowadays, men diagnosed with prostate cancer are often given two treatment choices, on opposite ends of the spectrum. First is active surveillance, where you forgo immediate treatment and monitor the cancer's growth. The other is surgery to remove the cancerous prostate.

But an in-between option might be a better choice for men who do not want the anxiety of wait-and-see or the physical hardship of surgery: radiation therapy.

Low levels of vitamin D may help predict aggressive prostate cancer, according to new research. While it only showed an association, the researchers believe low D levels could be used as a valuable biomarker, and help men and their doctors decide whether to consider active surveillance, in which the cancer is monitored for changes.